Andrew Cheng - President and CEO, Director at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
AKRO on Nasdaq
All Insider Reports
All Insider Reports

Andrew Cheng - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Andrew Cheng for Akero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 511K $24.3M $47.48 Nov 12, 2025 Direct
Stock Option (Right to Buy) 380K Oct 10, 2025 Direct Common Stock

Transactions reported by Andrew Cheng for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.